All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Myelogenous Leukemia

Chronic myelogenous leukemia (CML), otherwise called chronic myeloid leukemia, is a malignant growth of the white platelets. It is a type of leukemia portrayed by the expanded and unregulated development of myeloid cells in the bone marrow and the collection of these cells in the blood. CML is a clonal bone marrow undifferentiated cell issue in which a multiplication of develop granulocytes (neutrophils, eosinophils and basophils) and their antecedents is found. It is a kind of myeloproliferative neoplasm related with a trademark chromosomal translocation called the Philadelphia chromosome. CML is generally rewarded with focused medications called tyrosine-kinase inhibitors (TKIs) which have prompted significantly improved long haul endurance rates since 2001. These medications have changed treatment of this ailment and permit most patients to have a decent personal satisfaction when contrasted with the previous chemotherapy drugs. In Western nations, CML represents 15–25% of every single grown-up leukemia and 14% of leukemias by and large (counting the pediatric populace, where CML is less normal)

High Impact List of Articles

Relevant Topics in General Science

Google Scholar citation report
Citations : 627

Research & Reviews in BioSciences received 627 citations as per Google Scholar report

Indexed In

  • Google Scholar
  • Open J Gate
  • China National Knowledge Infrastructure (CNKI)
  • Cosmos IF
  • Directory of Research Journal Indexing (DRJI)
  • Scholarsteer
  • Secret Search Engine Labs
  • Euro Pub

View More